de Gaetano G - Search Results

1

Interaction between platelets and lupus anticoagulant.

Galli M, Cortelazzo S, Viero P, Finazzi G, de Gaetano G, Barbui T. Galli M, et al. Among authors: de gaetano g. Eur J Haematol. 1988 Jul;41(1):88-94. doi: 10.1111/j.1600-0609.1988.tb00874.x. Eur J Haematol. 1988. PMID: 2969826

2

In vitro platelet adhesion to vascular subendothelium: studies in patients with polycythaemia vera.

Lauri D, Dejana E, Cortelazzo S, Orlando E, Zanetti A, Viero P, de Gaetano G, Barbui T. Lauri D, et al. Among authors: de gaetano g. Eur J Haematol. 1988 Mar;40(3):262-6. doi: 10.1111/j.1600-0609.1988.tb00834.x. Eur J Haematol. 1988. PMID: 3356242

3

Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders.

Cortelazzo S, Galli M, Castagna D, Viero P, de Gaetano G, Barbui T. Cortelazzo S, et al. Among authors: de gaetano g. Thromb Haemost. 1988 Feb 25;59(1):73-6. Thromb Haemost. 1988. PMID: 3129810

4

Inhibition of ticlopidine of platelet adhesion to human venous subendothelium in patients with diabetes.

Orlando E, Cortelazzo S, Nosari I, Lepore G, Pagani G, de Gaetano G, Barbui T. Orlando E, et al. Among authors: de gaetano g. J Lab Clin Med. 1988 Nov;112(5):583-8. J Lab Clin Med. 1988. PMID: 3183491

5

Platelet dysfunction in splenectomized patients with hairy cell leukemia.

Cortelazzo S, Viero P, D'Emilio A, de Gaetano G, Barbui T. Cortelazzo S, et al. Among authors: de gaetano g. Eur J Cancer Clin Oncol. 1986 Aug;22(8):935-7. doi: 10.1016/0277-5379(86)90059-3. Eur J Cancer Clin Oncol. 1986. PMID: 3770050

6

Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.

Cortellazzo S, Viero P, Buczko W, Barbui T, de Gaetano G. Cortellazzo S, et al. Among authors: de gaetano g. Scand J Haematol. 1985 Feb;34(2):146-51. doi: 10.1111/j.1600-0609.1985.tb02247.x. Scand J Haematol. 1985. PMID: 3856312

7

Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: deficiency of an aspirin-independent mechanism?

Viero P, Cortelazzo S, Barbui T, de Gaetano G. Viero P, et al. Among authors: de gaetano g. Haemostasis. 1986;16(1):27-33. doi: 10.1159/000215266. Haemostasis. 1986. PMID: 3699584

8

Aspirin and risk of bleeding in patients with thrombocythemia.

Barbui T, Buelli M, Cortelazzo S, Viero P, De Gaetano G. Barbui T, et al. Among authors: de gaetano g. Am J Med. 1987 Aug;83(2):265-8. doi: 10.1016/0002-9343(87)90696-6. Am J Med. 1987. PMID: 3497579

9

Normal vascular prostacyclin generation in patients with chronic myeloproliferative disorders.

Cortelazzo S, Viero P, Morelli C, Barbui T, de Gaetano G. Cortelazzo S, et al. Among authors: de gaetano g. Thromb Res. 1985 Jul 1;39(1):139-41. doi: 10.1016/0049-3848(85)90129-x. Thromb Res. 1985. PMID: 3898466 No abstract available.

10

Impairment of primary haemostasis by low molecular weight heparins in rats.

Borowska A, Lauri D, Maggi A, Dejana E, de Gaetano G, Donati MB, Pangrazzi J. Borowska A, et al. Among authors: de gaetano g. Br J Haematol. 1988 Mar;68(3):339-44. doi: 10.1111/j.1365-2141.1988.tb04211.x. Br J Haematol. 1988. PMID: 3355792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

696 results

Search Page

Filters